GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Other Operating Expense

Oncimmune Holdings (LSE:ONC) Other Operating Expense : £2.75 Mil (TTM As of Aug. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Other Operating Expense?

Oncimmune Holdings's Other Operating Expense for the six months ended in Aug. 2024 was £3.51 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Aug. 2024 was £2.75 Mil.

Oncimmune Holdings's quarterly Other Operating Expense declined from Aug. 2023 (£2.71 Mil) to Feb. 2024 (£-0.75 Mil) but then increased from Feb. 2024 (£-0.75 Mil) to Aug. 2024 (£3.51 Mil).

Oncimmune Holdings's annual Other Operating Expense increased from May. 2022 (£1.80 Mil) to Aug. 2023 (£3.15 Mil) but then declined from Aug. 2023 (£3.15 Mil) to Aug. 2024 (£2.75 Mil).


Oncimmune Holdings Other Operating Expense Historical Data

The historical data trend for Oncimmune Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Other Operating Expense Chart

Oncimmune Holdings Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 Aug23 Aug24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.81 1.80 3.15 2.75

Oncimmune Holdings Semi-Annual Data
Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24 Aug24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.44 2.71 -0.75 3.51

Oncimmune Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £2.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oncimmune Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncimmune Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacturing, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.